Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport
Contact Us
Search
Close

D.C. Circuit Upholds CMS Price Transparency Rule

By Mark Faccenda (US), Jeff Wurzburg (US) & Hayley White (US) on December 29, 2020
Email this postTweet this postLike this postShare this post on LinkedIn

On December 29, 2020, three days before the implementation date, the U.S. Court of Appeals for the D.C. Circuit upheld the Centers for Medicare & Medicaid Services (“CMS”) price transparency final rule.  Beginning January 1, 2021, hospitals will be required to make public their standard charges for 300 shoppable services, including 70 services identified by CMS as required by the November 27, 2019 final rule.  Hospitals must report the following for each item or service:

  1. Gross charges;
  2. Payer-specific negotiated charges;
  3. Standardized discounted cash prices;
  4. De-identified minimum negotiated charges; and
  5. De-identified maximum negotiated charges.

Hospitals had argued that the final rule violated the section 2718(e) of the Public Health Service Act, the Administrative Procedure Act, and the First Amendment.  The Court, in an opinion written by Judge Tatel, held that section 2718(e) is “best interpreted as requiring disclosure of more than list prices.”  The Court rejected arguments regarding the complexity of implementing the transparency requirements, citing heavily to the final rule preamble text and responses to comments received.  Justice Tatel writes that “[t]he Secretary weighed the rule’s costs and benefits and made a reasonable judgment that the benefits of easing the burden for consumers justified the added burdens imposed on hospitals.”

The ruling comes on the heels of a December 18, 2020 CMS special alert reminding hospitals that the requirements are effective beginning January 1, 2021 and that CMS will monitor a “sample of hospitals” to determine compliance with its requirements (HL Pulse post here).  CMS has also created a website with other price transparency resources (HL Pulse post here). The incoming Biden Administration has not yet announced their approach to the policy of price transparency.

Please contact members of the Norton Rose Fulbright healthcare team if we can assist with your implementation of the price transparency requirements.

Photo of Mark Faccenda (US) Mark Faccenda (US)
Read more about Mark Faccenda (US)Email
Photo of Jeff Wurzburg (US) Jeff Wurzburg (US)
Read more about Jeff Wurzburg (US)Email
Photo of Hayley White (US) Hayley White (US)
Read more about Hayley White (US)Email
  • Posted in:
    Administrative and Regulatory
  • Blog:
    Health Law Pulse
  • Organization:
    Norton Rose Fulbright
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
  • About LexBlog
  • The Field We Built
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo